Olfr49, a member of the olfactory receptor protein family, operates as a G-protein-coupled receptor (GPCR) responsible for the recognition and transduction of odorant signals. It shares a 7-transmembrane domain structure with neurotransmitter and hormone receptors, signifying its essential role in initiating neuronal responses and the subsequent perception of smell. Being a part of the largest gene family in the genome, the olfactory receptor gene family, Olfr49's nomenclature is independent of other organisms. Inhibition of Olfr49 involves various chemicals targeting specific pathways. Rimonabant, through CB1 receptor antagonism, disrupts the endocannabinoid signaling pathway, altering neuronal responses to odorant signals and diminishing the perception of smell. Cyclopamine targets the Hedgehog signaling pathway, indirectly inhibiting Olfr49 by disrupting downstream events crucial for proper olfactory signal transduction. CAY10636 blocks the cAMP signaling pathway, influencing GPCR-mediated transduction of odorant signals, leading to reduced Olfr49 activation.
SR141716A acts as a CB1 receptor antagonist, inhibiting Olfr49 through modulation of the endocannabinoid signaling pathway, impacting olfactory signal transduction and reducing smell perception. Jervine disrupts Hedgehog signaling, indirectly inhibiting Olfr49 by interfering with downstream events essential for proper olfactory signal transduction. SQ22536 inhibits adenylate cyclase, disrupting cAMP signaling and GPCR-mediated transduction, thus diminishing Olfr49 activation. AM251, AM630, and MDL-12,330A antagonize CB1 or CB2 receptors, indirectly inhibiting Olfr49 through modulation of the endocannabinoid signaling pathway. SANT-1 and GANT-61 target Hedgehog signaling, indirectly suppressing Olfr49 by interfering with downstream events crucial for proper olfactory signal transduction. KH7 inhibits adenylate cyclase, interfering with cAMP signaling and GPCR-mediated transduction, ultimately diminishing Olfr49 activation. In summary, the inhibition of Olfr49 involves a diverse array of chemicals that act through distinct pathways, disrupting the normal function of this receptor and consequently impacting the perception of olfactory stimuli. Understanding these intricate interactions sheds light on the complex regulatory mechanisms governing olfactory perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Inhibits Olfr49 through antagonism of CB1 receptors, affecting the endocannabinoid signaling pathway. This disruption alters neuronal responses to odorant signals, diminishing the perception of smell. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Targets the Hedgehog signaling pathway, indirectly inhibiting Olfr49 by disrupting downstream events crucial for proper olfactory signal transduction and perception. | ||||||
Rimonabant Hydrochloride | 158681-13-1 | sc-212786 | 10 mg | $166.00 | 1 | |
Acts as a CB1 receptor antagonist, inhibiting Olfr49 through modulation of the endocannabinoid signaling pathway. This alteration affects olfactory signal transduction, reducing the perception of smell. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
Disrupts Hedgehog signaling, indirectly inhibiting Olfr49 by interfering with downstream events essential for proper olfactory signal transduction and subsequent perception. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
Inhibits adenylate cyclase, disrupting cAMP signaling and GPCR-mediated transduction of olfactory signals. This impedes Olfr49 activation, diminishing the neuronal response and smell perception. | ||||||
SANT-1 | 304909-07-7 | sc-203253 | 5 mg | $135.00 | 5 | |
Targets Hedgehog signaling, indirectly inhibiting Olfr49 by interfering with downstream events crucial for proper olfactory signal transduction and subsequent perception. | ||||||
AM-630 | 164178-33-0 | sc-200365B sc-200365 sc-200365A sc-200365C | 5 mg 10 mg 50 mg 100 mg | $78.00 $166.00 $634.00 $869.00 | 8 | |
Antagonizes CB2 receptors, indirectly inhibiting Olfr49 through modulation of the endocannabinoid signaling pathway. This alteration disrupts olfactory signal transduction, reducing smell perception. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $64.00 $131.00 $204.00 | 6 | |
Inhibits Hedgehog signaling, indirectly suppressing Olfr49 by disrupting downstream events essential for proper olfactory signal transduction and subsequent perception. | ||||||